Conatus pharmaceuticals inc. (CNAT)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Dec'12
Assets
Current assets:
Cash and cash equivalents

18,049

20,703

18,314

13,437

19,168

11,565

13,308

11,639

16,615

16,079

14,360

15,765

16,475

58,083

14,313

13,459

19,586

13,876

14,558

8,929

8,302

9,912

11,325

8,397

2,485

4,158

35,135

3,280

4,036

Marketable securities

-

-

4,368

15,312

14,665

29,127

36,312

46,079

50,136

58,774

70,823

72,433

64,065

18,931

16,750

16,743

12,984

22,632

28,903

39,141

22,700

27,159

30,602

38,566

48,596

52,194

-

-

3,989

Collaboration receivables

0

122

1,650

3,194

3,860

3,677

4,109

4,853

5,847

3,367

-

-

-

2,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

-

-

-

-

-

-

-

0

7,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,456

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

255

-

Prepaid and other current assets

591

781

1,179

3,468

2,633

3,057

3,170

2,176

1,231

1,004

1,339

1,017

889

937

1,137

876

1,849

1,982

879

559

541

796

796

639

687

545

613

157

76

Total current assets

18,640

21,606

25,511

35,411

40,326

47,426

56,899

64,747

73,829

79,224

86,523

96,215

81,431

80,452

32,201

31,079

34,420

38,490

44,342

48,630

31,544

37,868

42,723

47,603

51,769

56,898

60,205

3,693

8,101

Property and equipment, net

-

-

102

124

145

154

124

130

157

179

204

228

237

261

285

311

336

344

191

207

219

237

241

83

32

23

21

24

29

Other assets

147

221

550

631

1,707

1,223

1,119

2,023

2,660

2,538

2,538

2,538

1,884

1,609

876

876

876

892

77

327

558

342

267

77

77

14

14

1,539

14

Total assets

18,787

21,827

26,163

36,166

42,178

48,803

58,142

66,900

76,646

81,941

89,266

98,982

83,553

82,323

33,362

32,266

35,632

39,727

44,610

49,166

32,323

38,447

43,232

47,764

51,879

56,935

60,241

5,257

8,145

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses

665

1,064

3,013

8,609

7,292

6,216

9,123

11,635

14,644

11,962

10,937

8,710

5,697

5,311

2,354

1,995

2,192

2,545

2,252

2,531

2,249

3,003

3,172

2,464

2,160

1,494

774

1,353

1,087

Accrued compensation

251

238

303

783

935

2,230

1,976

1,485

1,095

2,008

1,810

1,366

938

2,351

1,609

1,239

891

1,436

1,392

1,130

875

1,171

1,261

796

456

1,322

381

370

325

Current portion of deferred revenue

-

-

404

2,130

8,150

10,075

12,661

-

-

14,172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of lease liabilities

229

338

439

419

398

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred revenue

-

-

-

-

-

-

-

14,430

14,868

-

19,454

24,630

27,449

30,897

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable

-

-

-

-

-

-

-

-

-

-

0

0

-

1,000

-

-

-

-

-

-

-

-

-

-

-

-

-

975

-

Total current liabilities

1,145

1,640

4,159

11,941

16,775

18,521

23,760

27,550

30,607

28,142

32,203

34,707

34,085

39,559

3,964

3,235

3,084

3,982

3,644

3,661

3,125

4,175

4,434

3,261

2,616

2,817

1,155

2,698

1,412

Deferred revenue, less current portion

-

-

0

0

1,576

2,815

3,962

-

-

12,519

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities, less current portion

-

-

-

116

229

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, less current portion

-

-

-

-

-

-

-

5,749

9,231

-

12,673

17,063

17,253

20,803

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note payable

-

-

-

-

-

-

13,718

13,530

13,343

13,158

12,968

12,779

12,592

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160

Convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,103

-

Note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

1,000

Deferred rent, less current portion

-

-

0

0

0

68

84

99

113

126

139

151

161

171

181

190

197

204

150

126

93

58

23

-

-

-

-

-

-

Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

Common stock, $0.0001 par value; 200,000 shares authorized; 33,170 shares issued and outstanding at March 31, 2020 and December 31, 2019

3

3

3

3

3

3

3

3

3

3

3

3

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

0

0

Additional paid-in capital

219,134

218,198

217,285

216,133

214,968

214,042

199,350

198,143

197,097

196,077

194,951

193,949

173,710

172,424

169,713

162,461

159,514

155,441

154,667

153,173

130,835

129,976

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

129,194

128,475

127,936

127,536

127,377

12,049

470

Accumulated other comprehensive loss

-

-

1

5

3

-17

-12

-41

-112

-77

-23

-22

-19

-6

8

18

5

-3

0

-9

-2

-13

-6

2

-1

11

11

-

0

Accumulated deficit

-201,495

-198,014

-195,285

-192,032

-191,376

-186,629

-182,723

-178,133

-173,636

-168,007

-163,650

-159,650

-154,233

-150,632

-141,508

-134,642

-128,170

-120,899

-114,854

-108,787

-102,730

-96,750

-91,414

-84,976

-

-74,430

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

79,673

-

69,304

65,984

58,807

Total stockholders’ equity

17,642

20,187

22,004

24,109

23,598

27,399

16,618

19,972

23,352

27,996

31,281

34,279

19,460

21,788

28,216

27,841

31,351

34,540

39,815

44,378

28,104

33,213

37,774

43,502

48,262

53,118

58,086

-53,934

-58,335

Total liabilities and stockholders’ equity

18,787

21,827

26,163

36,166

42,178

48,803

58,142

66,900

76,646

81,941

89,266

98,982

83,553

82,323

33,362

32,266

35,632

39,727

44,610

49,166

32,323

38,447

43,232

47,764

51,879

56,935

60,241

5,257

8,145